Literature DB >> 23561284

The making of 'the elderly': constructing the subject of care.

Bernhard Weicht1.   

Abstract

The provision and arrangement of care for elderly people is one of the main challenges for the future of European welfare states. In both political and public discourses elderly people feature as the subjects who are associated with particular needs, wishes and desires and for whom care needs to be guaranteed and organised. Underlying the cultural construction of the care regime and culture is an ideal type model of the elderly person. This paper analyses the discursive construction of elderly people in the discourses on care in Austria. An understanding of how elderly people as subjects, their wishes and needs and their position within society are constructed enables us to analyse, question and challenge the current dominant care arrangements and its cultural embeddings. The paper demonstrates the processes of silencing, categorisation and passivation of elderly people and it is argued that the socio-discursive processes lead to a particular image of the elderly person which consequently serves as the basis on which the care regime is built.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23561284     DOI: 10.1016/j.jaging.2013.03.001

Source DB:  PubMed          Journal:  J Aging Stud        ISSN: 0890-4065


  2 in total

1.  Analysis of newspaper coverage of active aging through the lens of the 2002 World Health Organization Active Ageing Report: A Policy Framework and the 2010 Toronto Charter for Physical Activity: A Global Call for Action.

Authors:  Boushra Abdullah; Gregor Wolbring
Journal:  Int J Environ Res Public Health       Date:  2013-12-05       Impact factor: 3.390

2.  Negotiating agency and belonging during the first lockdown of the COVID-19 pandemic: an interview study among older adults in England, UK.

Authors:  Brianne Wenning; Kay Polidano; Christian Mallen; Lisa Dikomitis
Journal:  BMJ Open       Date:  2022-05-09       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.